315 related articles for article (PubMed ID: 17761758)
21. Only fat infiltrated muscles in resting lower leg of FSHD patients show disturbed energy metabolism.
Kan HE; Klomp DW; Wohlgemuth M; van Loosbroek-Wagemans I; van Engelen BG; Padberg GW; Heerschap A
NMR Biomed; 2010 Jul; 23(6):563-8. PubMed ID: 20175146
[TBL] [Abstract][Full Text] [Related]
22. Non-myogenic mesenchymal cells contribute to muscle degeneration in facioscapulohumeral muscular dystrophy patients.
Di Pietro L; Giacalone F; Ragozzino E; Saccone V; Tiberio F; De Bardi M; Picozza M; Borsellino G; Lattanzi W; Guadagni E; Bortolani S; Tasca G; Ricci E; Parolini O
Cell Death Dis; 2022 Sep; 13(9):793. PubMed ID: 36114172
[TBL] [Abstract][Full Text] [Related]
23. Typical facioscapulohumeral dystrophy phenotype in patients without FSHD 4q35 deletion.
Krasnianski M; Neudecker S; Eger K; Jakubiczka S; Zierz S
J Neurol; 2003 Sep; 250(9):1084-7. PubMed ID: 14504970
[TBL] [Abstract][Full Text] [Related]
24. Lung and respiratory muscle function in facioscapulohumeral muscular dystrophy.
Stübgen JP; Schultz C
Muscle Nerve; 2009 Jun; 39(6):729-34. PubMed ID: 19301367
[TBL] [Abstract][Full Text] [Related]
25. Rimmed vacuoles in facioscapulohumeral muscular dystrophy: a unique ultrastructural feature.
Neudecker S; Krasnianski M; Bahn E; Zierz S
Acta Neuropathol; 2004 Sep; 108(3):257-9. PubMed ID: 15221332
[TBL] [Abstract][Full Text] [Related]
26. Retinal vascular disease and the pathogenesis of facioscapulohumeral muscular dystrophy. A signalling message from Wnt?
Fitzsimons RB
Neuromuscul Disord; 2011 Apr; 21(4):263-71. PubMed ID: 21377364
[TBL] [Abstract][Full Text] [Related]
27. Fusion-independent expression of functional ACh receptors in mouse mesoangioblast stem cells contacting muscle cells.
Grassi F; Pagani F; Spinelli G; De Angelis L; Cossu G; Eusebi F
J Physiol; 2004 Oct; 560(Pt 2):479-89. PubMed ID: 15319417
[TBL] [Abstract][Full Text] [Related]
28. Myoblasts from affected and non-affected FSHD muscles exhibit morphological differentiation defects.
Barro M; Carnac G; Flavier S; Mercier J; Vassetzky Y; Laoudj-Chenivesse D
J Cell Mol Med; 2010 Jan; 14(1-2):275-89. PubMed ID: 18505476
[TBL] [Abstract][Full Text] [Related]
29. Mobility assessment of patients with facioscapulohumeral dystrophy.
Iosa M; Mazzà C; Frusciante R; Zok M; Aprile I; Ricci E; Cappozzo A
Clin Biomech (Bristol, Avon); 2007 Dec; 22(10):1074-82. PubMed ID: 17850940
[TBL] [Abstract][Full Text] [Related]
30. Premature proliferative arrest of cricopharyngeal myoblasts in oculo-pharyngeal muscular dystrophy: Therapeutic perspectives of autologous myoblast transplantation.
Périé S; Mamchaoui K; Mouly V; Blot S; Bouazza B; Thornell LE; St Guily JL; Butler-Browne G
Neuromuscul Disord; 2006 Nov; 16(11):770-81. PubMed ID: 17005403
[TBL] [Abstract][Full Text] [Related]
31. Progenitor cell isolation from muscle-derived cells based on adhesion properties.
Rouger K; Fornasari B; Armengol V; Jouvion G; Leroux I; Dubreil L; Feron M; Guevel L; Cherel Y
J Histochem Cytochem; 2007 Jun; 55(6):607-18. PubMed ID: 17312016
[TBL] [Abstract][Full Text] [Related]
32. [Mechanism of translocation between chromosomes 4q and 10q in facioscapulohumeral muscular dystrophy].
Wang N; Wu ZY; Wang CD; Wang ZQ; Lin MT; Fang L; Murong SX
Zhonghua Yi Xue Za Zhi; 2003 Apr; 83(8):650-3. PubMed ID: 12887821
[TBL] [Abstract][Full Text] [Related]
33. Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q.
Jiang G; Yang F; van Overveld PG; Vedanarayanan V; van der Maarel S; Ehrlich M
Hum Mol Genet; 2003 Nov; 12(22):2909-21. PubMed ID: 14506132
[TBL] [Abstract][Full Text] [Related]
34. Sarcolemmal reorganization in facioscapulohumeral muscular dystrophy.
Reed P; Porter NC; Strong J; Pumplin DW; Corse AM; Luther PW; Flanigan KM; Bloch RJ
Ann Neurol; 2006 Feb; 59(2):289-97. PubMed ID: 16437580
[TBL] [Abstract][Full Text] [Related]
35. A unique library of myogenic cells from facioscapulohumeral muscular dystrophy subjects and unaffected relatives: family, disease and cell function.
Homma S; Chen JC; Rahimov F; Beermann ML; Hanger K; Bibat GM; Wagner KR; Kunkel LM; Emerson CP; Miller JB
Eur J Hum Genet; 2012 Apr; 20(4):404-10. PubMed ID: 22108603
[TBL] [Abstract][Full Text] [Related]
36. Novel mitochondrial tRNA Leu(CUN) transition and D4Z4 partial deletion in a patient with a facioscapulohumeral phenotype.
Filosto M; Tonin P; Scarpelli M; Savio C; Greco F; Mancuso M; Vattemi G; Govoni V; Rizzuto N; Tupler R; Tomelleri G
Neuromuscul Disord; 2008 Mar; 18(3):204-9. PubMed ID: 18343111
[TBL] [Abstract][Full Text] [Related]
37. [Progress in researches on the molecular genetics of facioscapulohumeral muscular dystrophy].
Su Q; Zhang C
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Oct; 18(5):398-401. PubMed ID: 11592052
[TBL] [Abstract][Full Text] [Related]
38. Molecular diagnosis of facioscapulohumeral muscular dystrophy.
Upadhyaya M; Cooper DN
Expert Rev Mol Diagn; 2002 Mar; 2(2):160-71. PubMed ID: 11962336
[TBL] [Abstract][Full Text] [Related]
39. DUX4-induced constitutive DNA damage and oxidative stress contribute to aberrant differentiation of myoblasts from FSHD patients.
Dmitriev P; Bou Saada Y; Dib C; Ansseau E; Barat A; Hamade A; Dessen P; Robert T; Lazar V; Louzada RAN; Dupuy C; Zakharova V; Carnac G; Lipinski M; Vassetzky YS
Free Radic Biol Med; 2016 Oct; 99():244-258. PubMed ID: 27519269
[TBL] [Abstract][Full Text] [Related]
40. Alteration of expression of muscle specific isoforms of the fragile X related protein 1 (FXR1P) in facioscapulohumeral muscular dystrophy patients.
Davidovic L; Sacconi S; Bechara EG; Delplace S; Allegra M; Desnuelle C; Bardoni B
J Med Genet; 2008 Oct; 45(10):679-85. PubMed ID: 18628314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
